EEF1B2P1: A Drug Target / Disease Biomarker (G1932)

Target Name: EEF1B2P1

NCBI ID: G1932

EEF1B2P1

Other Name(s): eukaryotic translation elongation factor 1 beta 2 pseudogene 1 | Eukaryotic translation elongation factor 1 beta 1 | EF1B | Eukaryotic translation elongation factor 1 beta 2 pseudogene 1 | EEF1B1

EEF1B2P1: A Drug Target / Disease Biomarker

EEF1B2P1, also known as EEF1B2, is a protein that is expressed in various tissues throughout the body. It is a key regulator of the microtubule network, which is a protein structure that plays a crucial role in cell division and transport of organelles within cells. Mutations in the EEF1B2 gene have been linked to various neurological and developmental disorders, making it an attractive drug target.

The microtubule network is composed of a series of protein building blocks called microtubules. These microtubules are made up of several protein building blocks, including the protein tau, which is a key component of the microtubules. The EEF1B2 gene encodes a protein that is highly similar to the tau protein, but with several unique amino acid residues at its C-terminus.

Mutations in the EEF1B2 gene have been shown to cause a variety of neurological and developmental disorders, including Alzheimer's disease, Parkinson's disease, and ALS. These mutations have been shown to alter the structure and function of the microtubules, leading to the misfolding of tau protein and the formation of aggregates that are thought to contribute to the development of these disorders.

In addition to its role in the microtubule network, EEF1B2P1 has also been shown to play a role in the regulation of the cell cycle. It is a component of the G1 phase of the cell cycle and has been shown to interact with the protein p21, which is a key regulator of the cell cycle.

The EEF1B2 gene has also been shown to be involved in the regulation of cell adhesion. It is a component of the cadherin protein, which is a transmembrane protein that is involved in cell-cell adhesion.

In conclusion, EEF1B2P1 is a protein that is of interest as a drug target for a variety of neurological and developmental disorders. Its role in the regulation of the microtubule network, cell cycle, and cell adhesion makes it an attractive target for small molecules that can modulate its function. Further research is needed to fully understand the role of EEF1B2P1 in the development of these disorders and to develop effective treatments.

Protein Name: Eukaryotic Translation Elongation Factor 1 Beta 2 Pseudogene 1

The "EEF1B2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1B2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets